The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leite-de-Moraes, M. C.
Right arrow Articles by Dy, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leite-de-Moraes, M. C.
Right arrow Articles by Dy, M.

The Journal of Immunology, Vol 155, Issue 10 4544-4550, Copyright © 1995 by American Association of Immunologists


ARTICLES

MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response

MC Leite-de-Moraes, A Herbelin, F Machavoine, A Vicari, JM Gombert, M Papiernik and M Dy
Rene Descartes University, Paris, France.

Differentiation of naive CD4+ lymphocytes into either Th1 or Th2 cells is influenced by the cytokine present during initial Ag priming. IL-4 is the critical element in the induction of Th2 response; however, its origin during a primary immune response is not well defined. In the present study, we characterized a novel potential source of IL-4, the class I-selected CD4-CD8-TCR-alpha beta+ T cells. In a first set of experiments, we demonstrated that CD4-CD8-TCR-alpha beta+ thymocytes produce a large amount of IL-4 after in vitro anti-CD3 stimulation. This phenomenon was not observed in class I-deficient mice, demonstrating that among these cells, the class I-selected subset was predominantly responsible for IL-4 production. Further studies focused on the in vivo IL-4-producing capacity of peripheral CD4-CD8-TCR-alpha beta+ T cells. To this end, a single injection of anti-CD3 mAb, which promptly induces IL-4 mRNA expression, was used. Peripheral CD4-CD8-TCR- alpha beta+ T cells express high levels of IL-4 mRNA in response to in vivo anti-CD3 challenge. Furthermore, analysis performed in mice lacking MHC class I or class II molecules demonstrates that both the class I-selected subset of CD4-CD8-TCR+ and CD4+ peripheral T lymphocytes are the major IL-4 producers after in vivo anti-CD3 stimulation. These findings suggest that class I-selected CD4-CD8-TCR- alpha beta+ and CD4+ T cell populations are important sources of IL-4 probably implicated in the development of specific Th2 immune responses.


This article has been cited by other articles:


Home page
J. Immunol.Home page
D. S. Vinay, B. K. Choi, J. S. Bae, W. Y. Kim, B. M. Gebhardt, and B. S. Kwon
CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, and Have Lower IL-4 Responses
J. Immunol., September 15, 2004; 173(6): 4218 - 4229.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Schneider, M.-B. Tonanny, M. Lisbonne, M. Leite-de-Moraes, and M. Dy
Pro-Th1 Cytokines Promote Fas-Dependent Apoptosis of Immature Peripheral Basophils
J. Immunol., May 1, 2004; 172(9): 5262 - 5268.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Yang, M. Bao, and J.-W. Yoon
Intrinsic Defects in the T-Cell Lineage Results in Natural Killer T-Cell Deficiency and the Development of Diabetes in the Nonobese Diabetic Mouse
Diabetes, December 1, 2001; 50(12): 2691 - 2699.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Till, L. A. Jopling, P. A. Wachholz, R. L. Robson, S. Qin, D. P. Andrew, L. Wu, J. van Neerven, T. J. Williams, S. R. Durham, et al.
T Cell Phenotypes of the Normal Nasal Mucosa: Induction of Th2 Cytokines and CCR3 Expression by IL-4
J. Immunol., February 15, 2001; 166(4): 2303 - 2310.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Leite-de-Moraes, A. Hameg, M. Pacilio, Y. Koezuka, M. Taniguchi, L. Van Kaer, E. Schneider, M. Dy, and A. Herbelin
IL-18 Enhances IL-4 Production by Ligand-Activated NKT Lymphocytes: A Pro-Th2 Effect of IL-18 Exerted Through NKT Cells
J. Immunol., January 15, 2001; 166(2): 945 - 951.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Hameg, I. Apostolou, M. Leite-de-Moraes, J.-M. Gombert, C. Garcia, Y. Koezuka, J.-F. Bach, and A. Herbelin
A Subset of NKT Cells That Lacks the NK1.1 Marker, Expresses CD1d Molecules, and Autopresents the {alpha}-Galactosylceramide Antigen
J. Immunol., November 1, 2000; 165(9): 4917 - 4926.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Leite-de-Moraes, A. Herbelin, C. Gouarin, Y. Koezuka, E. Schneider, and M. Dy
Fas/Fas Ligand Interactions Promote Activation-Induced Cell Death of NK T Lymphocytes
J. Immunol., October 15, 2000; 165(8): 4367 - 4371.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Leite-de-Moraes, A. Hameg, A. Arnould, F. Machavoine, Y. Koezuka, E. Schneider, A. Herbelin, and M. Dy
A Distinct IL-18-Induced Pathway to Fully Activate NK T Lymphocytes Independently from TCR Engagement
J. Immunol., December 1, 1999; 163(11): 5871 - 5876.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Q. Khan, J. M. Penninger, L. Yang, L. E. Marra, I. Kozieradzki, and L. Zhang
Regulation of Apoptosis in Mature {alpha}{beta}+CD4-CD8- Antigen-Specific Suppressor T Cell Clones
J. Immunol., May 15, 1999; 162(10): 5860 - 5867.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Wang, C. A. Ellison, J. G. Gartner, and K. T. HayGlass
Natural Killer Cell Depletion Fails to Influence Initial CD4 T Cell Commitment In Vivo in Exogenous Antigen-Stimulated Cytokine and Antibody Responses
J. Immunol., February 1, 1998; 160(3): 1098 - 1105.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.